HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jerri M Rook Selected Research

VU0410120

8/2015Effects of VU0410120, a novel GlyT1 inhibitor, on measures of sociability, cognition and stereotypic behaviors in a mouse model of autism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jerri M Rook Research Topics

Disease

18Schizophrenia (Dementia Praecox)
12/2019 - 12/2010
6Alzheimer Disease (Alzheimer's Disease)
12/2019 - 01/2014
3Seizures (Absence Seizure)
01/2019 - 09/2013
3Wounds and Injuries (Trauma)
06/2009 - 09/2007
2Central Nervous System Diseases (CNS Diseases)
08/2021 - 09/2013
2Brain Diseases (Brain Disorder)
10/2018 - 02/2015
2Autistic Disorder (Autism)
01/2016 - 08/2015
2Pain (Aches)
06/2009 - 09/2007
1Dystonia (Limb Dystonia)
08/2021
1Movement Disorders (Movement Disorder)
08/2021
1Parkinson Disease (Parkinson's Disease)
08/2021
1Neurodevelopmental Disorders
01/2021
1Syndrome (Syndromes)
01/2017
1Substance-Related Disorders (Drug Abuse)
03/2016
1Cocaine-Related Disorders (Cocaine Addiction)
03/2016
1Cognitive Dysfunction
01/2016
1Autism Spectrum Disorder
08/2015
1Bipolar Disorder (Manic Depressive Psychosis)
01/2015
1Psychotic Disorders (Schizoaffective Disorder)
01/2014
1Neurogenic Inflammation
07/2008
1Cicatrix (Scar)
07/2008
1Pressure Ulcer (Bedsore)
09/2007
1Burns
09/2007

Drug/Important Bio-Agent (IBA)

8Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
08/2021 - 01/2014
7Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
10/2018 - 12/2010
4Cholinergic Agents (Cholinergics)IBA
01/2019 - 09/2016
3Metabotropic Glutamate 5 ReceptorIBA
03/2016 - 10/2013
3Morphine (MS Contin)FDA LinkGeneric
06/2009 - 09/2007
3Opioid Analgesics (Opioids)IBA
06/2009 - 09/2007
3NeuropeptidesIBA
06/2009 - 09/2007
2Muscarinic M4 ReceptorIBA
10/2018 - 01/2014
2Proteins (Proteins, Gene)FDA Link
10/2018 - 01/2016
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2016 - 08/2015
2Substance PIBA
06/2009 - 09/2007
2Neurokinin AIBA
06/2009 - 09/2007
2IntraSite GelIBA
07/2008 - 09/2007
1Muscarinic AntagonistsIBA
08/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
08/2021
1metabotropic glutamate receptor 7IBA
01/2021
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2021
1Amphetamine (Amfetamine)FDA LinkGeneric
10/2018
1Hydroxyl RadicalIBA
09/2018
1Muscarinic M1 ReceptorIBA
10/2017
1Glutamic Acid (Glutamate)FDA Link
10/2017
1Phencyclidine (Angel Dust)IBA
10/2017
1Pharmaceutical PreparationsIBA
01/2017
1Antipsychotic Agents (Antipsychotics)IBA
09/2016
1VU0410120IBA
08/2015
1VU0409551IBA
06/2015
1N-Methylaspartate (NMDA)IBA
05/2015
1Glutamate Receptors (Glutamate Receptor)IBA
05/2015
1metabotropic glutamate receptor 3 (mGluR3)IBA
01/2015
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
09/2013
1Capsaicin (Zostrix)FDA Link
06/2009
1Hematoxylin (Haematoxylon)IBA
07/2008
1Eosine Yellowish-(YS) (Eosin)IBA
07/2008
1Analgesics (Analgesic Drugs)IBA
07/2008
1Sulfates (Sulfates, Inorganic)IBA
09/2007
1TachykininsIBA
09/2007
1Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA
09/2007

Therapy/Procedure

2Therapeutics
08/2021 - 09/2007
2Topical Administration
07/2008 - 09/2007
1Drug Therapy (Chemotherapy)
03/2016
1Analgesia
09/2007